Erasca, Inc. (ERAS)

Erasca Market Cap

Erasca has a market cap or net worth of $338.05 million as of May 17, 2024. Its market cap has decreased by -25.42% in one year.

• Market Cap: 338.05M
• Enterprise Value: 94.89M
• 1-Year Change: -25.42%
• Ranking: #3277
• Category: Small-Cap
• Stock Price: $1.97

Market Cap Chart

Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $338.05M, a decrease of -81.81%. That is a compound annual growth rate of -45.14%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	341.50M	6.49%
May 16, 2024	320.70M	-2.11%
May 15, 2024	327.60M	1.61%
May 14, 2024	322.40M	-2.13%
May 13, 2024	329.40M	2.71%
May 10, 2024	320.70M	-5.62%
May 9, 2024	339.80M	-8.83%
May 8, 2024	372.70M	12.84%
May 7, 2024	330.30M	-1.34%
May 6, 2024	334.80M	3.27%
May 3, 2024	324.20M	-0.46%
May 2, 2024	325.70M	2.87%
May 1, 2024	316.60M	3.97%
Apr 30, 2024	304.50M	-1.46%
Apr 29, 2024	309.00M	7.93%
Apr 26, 2024	286.30M	0.53%
Apr 25, 2024	284.80M	-
Apr 24, 2024	284.80M	-2.60%
Apr 23, 2024	292.40M	4.32%
Apr 22, 2024	280.30M	3.36%
Apr 19, 2024	271.20M	-
Apr 18, 2024	271.20M	-2.69%
Apr 17, 2024	278.70M	-4.69%
Apr 16, 2024	292.40M	-3.50%
Apr 15, 2024	303.00M	-5.22%

View and export this data all the way back to 2021. Sign Up Today.

Related Stocks

Company	Market Cap
Tenaya Therapeutics	349.40M
Zynex	348.26M
Pulmonx	347.01M
Jasper Therapeutics	346.82M
Solid Biosciences	340.75M
Nanobiotix	338.73M
Skye Bioscience	337.10M
Alto Neuroscience	336.05M